Michael H. Davidson New Amsterdam Pharma CO N.V. (NAMS) insider trading activity

Shares Held (Direct Ownership) 390K

216.07% 3M change

n/a 12M change

Total Value Held N/A

Michael H. Davidson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 26 2025	SELL Open market or private sale	-	12,258 Reduced 3.04%	390,441 Ordinary Shares
Mar 26 2025	BUY Grant, award, or other acquisition	-	30,992 Added 7.84%	364,305 Ordinary Shares
Mar 26 2025	BUY Exercise of conversion of derivative security	-	38,394 Added 8.7%	402,699 Ordinary Shares
Jan 07 2025	BUY Grant, award, or other acquisition	-	123,529 Added 50.0%	123,529 Ordinary Shares
Aug 20 2024	BUY Open market or private purchase	$81,350 $16.27 p/Share	5,000 Added 2.33%	209,784 Ordinary Shares
Jun 20 2024	BUY Open market or private purchase	$86,300 $17.26 p/Share	5,000 Added 2.38%	204,784 Ordinary Shares

SLN

Silence Therapeutics plc Healthcare

CLBS

CALADRIUS BIOSCIENCES, INC. Healthcare

Director

TENX

TENAX THERAPEUTICS, INC. Healthcare

BIOA

BioAge Labs, Inc.

MHD

Chief Executive Officer

Basking Ridge, NJ

Receive a notification when an Institution or Guru buys or sells NAMS shares.

Notify only if

Value

Get notified when an New Amsterdam Pharma CO N.V. insider buys or sells NAMS shares.

Notify only if

Operation

Value

Type

Receive news related to NewAmsterdam Pharma Co N.V.